Mei Hui Li

Director/Board Member at CTCI ADVANCED SYSTEMS INC.

Producer Manufacturing

Commercial Services

Consumer Services

Profile

Mei Hui Li is currently the Vice Chairman & Chief Executive Officer at Cinemark Co. Ltd. She also holds positions as an Independent Director at CTCI Advanced Systems Inc., FOCI Fiber Optic Communications, Inc., and Director at Advagene Biopharma Co., Ltd. Ms. Li previously worked as the Managing Director at Taiwan Secom Co., Ltd. She graduated from National Taiwan University.

Mei Hui Li active positions

Companies	Position	Start
CTCI ADVANCED SYSTEMS INC.	Director/Board Member	26/06/2014
FOCI FIBER OPTIC COMMUNICATIONS, INC.	Director/Board Member	06/06/2018
ADVAGENE BIOPHARMA CO., LTD.	Director/Board Member	-
Cinemark Co. Ltd.	Chief Executive Officer	-

All active positions of Mei Hui Li

Former positions of Mei Hui Li

Companies	Position	End
TAIWAN SECOM CO., LTD.	Corporate Officer/Principal	-

See the detail of Mei Hui Li's experience

Training of Mei Hui Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mei Hui Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Taiwan Secom Co., Ltd. Taiwan Secom Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides system security services	Commercial Services
CTCI Advanced Systems Inc. CTCI Advanced Systems Inc. Electrical ProductsProducer Manufacturing Manufactures control system software and hardware	Producer Manufacturing
National Taiwan University National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
FOCI Fiber Optic Communications, Inc. FOCI Fiber Optic Communications, Inc. Electrical ProductsProducer Manufacturing Manufactures and sells fiber optic interconnectors	Producer Manufacturing
Cinemark Co. Ltd.
Advagene Biopharma Co., Ltd. Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy	Health Technology

See company connections